ProTechSure Scientific, Inc.   Report issue

For profit Phase 2
Founded: Aurora CO United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2015
NCT02534129
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

petrolatum, white (Vaseline) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Radiodermatitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1